December 7, 2023
|
The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services - at-home rapid tests, telehealth sessions and at-home treatments - to eligible participants nationwide. Home Test to Treat, which is a collaboration among the National Institutes of Health (NIH), the Administration for Strategic Preparedness and Response (ASPR), and the Centers for Disease Control and Prevention (CDC), launched as a pilot in select locations earlier this year. With its expansion, the Home Test to Treat program will now offer free testing, telehealth and treatment for both COVID-19 and for influenza (flu) A and B. It is the first public health program that includes home testing technology at such a scale for both COVID-19 and flu. The program initially will provide the LUCIRA® by Pfizer COVID-19 & Flu Home Test, the first U.S. Food and Drug Administration-authorized test that can detect both viruses in a single test at home. For those indicated, treatment must begin within a limited window from the onset of symptoms, underscoring the importance of continuity of care, from diagnosis to treatment. In addition, providing these services virtually, while individuals remain at home, is intended to expedite the time to treatment and the convenience of accessing services virtually from home. Any adult (18 years and older) with current positive test results for COVID-19 or flu can enroll to receive free telehealth care and, if prescribed, medication delivered to their homes. Adults who do not have COVID-19 or flu may enroll and receive free tests if they are uninsured or are enrolled in Medicare, Medicaid, the Veterans Affairs healthcare system, or Indian Health Services. If recipients test positive in the future, they can receive free telehealth care and, if prescribed, treatment. Click here to access the Home Test to Treat webpage for more information. |
